Journal article
Multigene panels in prostate cancer risk assessment.
Abstract
OBJECTIVES: The aim of this review is to identify, synthesize, and appraise the literature on the analytic validity, clinical validity, and clinical utility of commercially available single nucleotide polymorphism (SNP) panel tests for assessing the risk of prostate cancer.
DATA SOURCES: MEDLINE®, Cochrane CENTRAL, Cochrane Database of Systematic Reviews, and Embase, from the beginning of each database to October 2011. Search strategies used …
Authors
Little J; Wilson B; Carter R; Walker K; Santaguida P; Tomiak E; Beyene J; Raina P
Journal
Evidence Report Technology Assessment, , No. 209, pp. 1–166
Publication Date
7 2012
ISSN
1530-4396